Board Meeting27 May 2026, 10:41 pm
Parmax Pharma Board Meeting on 30 May 2026
AI Summary
Parmax Pharma Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the quarter/financial year ended March 31, 2026. In compliance with SEBI regulations, the trading window for dealing in the company's securities remains closed until 48 hours after the announcement of the results.
Key Highlights
- Parmax Pharma to consider audited financial results on May 30, 2026.
- Meeting is for the quarter/financial year ending March 31, 2026.
- Trading window closed until 48 hours post result announcement as per SEBI norms.